文献速递免疫规划

9R禽伤寒活疫苗在鹧鸪物种中的安全性与效力

Safety and efficacy of 9R live attenuated vaccine against fowl typhoid in partridge's species.
PubMed 文献 · Vaccine · 2024-10-11

研究评估本地生产的9R禽伤寒活疫苗在鹧鸪中的安全性与效力。6周龄首免、6周后二免,14周龄用禽伤寒沙门菌MSG1强毒株攻击。免疫组保护率为65%,器官侵袭减少;作者认为该活疫苗可安全用于减少鹧鸪群损失并有助于减少感染。

要点

  • 6周龄首免、6周后二免的9R活疫苗在鹧鸪中安全性良好。
  • 14周龄强毒株攻击后,免疫组保护率为65%,器官侵袭较未免疫组减少。

核心结论

  • 作者认为,9R活疫苗可安全用于鹧鸪以减少群损失并有助于减少禽伤寒感染。

研究设计与样本

  • 研究将鹧鸪分组,6周龄接种本地生产的9R禽伤寒活疫苗,6周后第二次注射,14周龄用禽伤寒沙门菌(Salmonella gallinarum)MSG1强毒株进行攻击试验。

主要发现

  • 攻击试验显示,免疫攻击组保护率为65%,器官侵袭较未免疫对照组减少。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Fowl typhoid is a significant avian disease worldwide affecting mainly chickens, turkeys and other bird species, such as partridges. In Morocco, the disease causes a high mortality rate in farmed partridges. Vaccination of partridges is a priority to preserve the breed however; the vaccine has never been evaluated in this species. The study was conducted to assess safety and efficacy of a locally produced Salmonella 9R live vaccine in partridges. Groups of vaccinated partridges received the vaccine at 6 weeks of age, followed by a second injection 6 weeks after. The challenge test was performed at 14 weeks with Salmonella gallinarum MSG1 virulent strain. The challenge demonstrated 65 % protection in vaccinated challenged partridges, with a reduction in organ invasion compared to unvaccinated control birds, which exhibited 70,6 % mortality. The live attenuated 9R vaccine, could be safely used to reduce flock losses and contribute to the reduction of infection.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bamouh Z, Semmate N, Mouahid M, et al. Safety and efficacy of 9R live attenuated vaccine against fowl typhoid in partridge's species. Vaccine. 2024. PMID: 39393168. doi:10.1016/j.vaccine.2024.126413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。